[1]
ShahT., LiddleR., BranchM., JowellP., ObandoJ. and PoleskiM. 2012. Pilot Study of Aprepitant for Prevention of Post-ERCP Pancreatitis in High Risk Patients: A Phase II Randomized, Double-Blind Placebo Controlled Trial. JOP. Journal of the Pancreas. 13, 5 (Sep. 2012), 514-518. DOI:https://doi.org/10.6092/1590-8577/855.